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Abstract
 
Extensive studies of mice deficient in one or several cytokine receptors have failed to support
an indispensable role of cytokines in development of multiple blood cell lineages. Whereas B1
B cells and Igs are sustained at normal levels throughout life of mice deficient in IL-7, IL-7R
 
 
 
,
common cytokine receptor gamma chain, or flt3 ligand (FL), we report here that adult mice
double deficient in IL-7R
 
 
 
 and FL completely lack visible LNs, conventional IgM
 
 
 
 B cells,
IgA
 
 
 
 plasma cells, and B1 cells, and consequently produce no Igs. All stages of committed B
cell progenitors are undetectable in FL
 
 
 
/
 
  
 
  
 
IL-7R
 
 
 
 
 
/
 
 
 
 BM that also lacks expression of the B
 
cell commitment factor 
 
Pax5
 
 and its direct target genes. Furthermore, in contrast to IL-7R
 
 
 
 
 
/
 
 
 
mice, FL
 
 
 
/
 
  
 
  
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice also lack mature B cells and detectable committed B cell
progenitors during fetal development. Thus, signaling through the cytokine tyrosine kinase
receptor flt3 and IL-7R
 
 
 
 are indispensable for fetal and adult B cell development.
Key words: lymphopoiesis • IL-7 receptor • Flt3 ligand • Pax5 • B1 cells
 
Introduction
 
Hematopoiesis is a tightly regulated process in which multi-
potent hematopoietic stem cells commit and differentiate
along a number of specific pathways to continuously replen-
ish cells of all blood lineages (1). Several lineage restricted
hematopoietic growth factors (cytokines) and their corre-
sponding receptors promote the development of specific
blood cell lineages in vitro and in vivo (2–5). However,
targeted deletions of most of these cytokine receptors or
their ligands have resulted in surprisingly mild phenotypes
and rarely in complete losses of specific blood cell lineages
(3, 6–12). Furthermore, since the physiological functions of
most blood lineages remain intact at reduced cell numbers,
such mutations frequently have limited or no functional con-
sequences. For instance, although thrombopoietin-deficient
mice have an 85% reduction in platelets, they have no
bleeding disorder (13).
As a result of these observations, the concept and contro-
versy of cytokine redundancy has emerged, implicating that
many lineage-restricted cytokines may play a limited role in
the regulation of hematopoiesis. This latter point also raises
the possibility that combinatorial interactions between two
or more cytokines may frequently be required for develop-
ment of specific blood cell lineages (3). The last possibility
 
Address correspondence to Sten Eirik W. Jacobsen, Hematopoietic Stem
Cell Laboratory, Lund Strategic Research Center for Stem Cell Biology
and Cell Therapy, Lund University Hospital, BMC 10, Klinikgatan 26,
221-84 Lund, Sweden. Phone: 46-46-2224852; Fax: 46-46-2223600;
email: Sten.Jacobsen@stemcell.lu.se
 
Abbreviations used in this paper: 
 
AP, alkaline phosphatase;
 
 
 
CLP, common
lymphoid progenitor;
 
 
 
FL, flt3 ligand;
 
 
 
PB, peripheral blood; 
 
 
 
c, 
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has already provoked extensive research but so far provided
limited evidence for the requirement of such in vivo syn-
ergy between lineage-restricted cytokines and, for instance,
in myeloid development failed to support an absolute com-
binatorial cytokine requirement for the formation of both
platelets and granulocytes (14–24).
Several cytokines have been implicated to be involved
in the regulation of B cell development (25). Of these,
IL-7 has emerged as a key cytokine involved in B cell
genesis (9, 26, 27). However, recent studies have demon-
strated that although B cell development is almost com-
pletely arrested at a very early stage in the BM of adult
IL-7 and IL-7R
 
 
 
–deficient mice, a pool of mature B
cells, primarily of fetal and perinatal origin, is sustained
and stable throughout adult life, capable of producing
normal levels of Igs (28–30). Furthermore, the compart-
ment of self-replenishing B1 cells is normal in IL-7–defi-
cient mice and has therefore been suggested to be IL-7
independent (28).
Whether IL-7 in combination with other cytokines
might be indispensable for B cell genesis has been thor-
oughly investigated in mice with targeted deletions of
the common 
 
 
 
 receptor chain (
 
 
 
c), essential for signaling
by six lymphokines (IL-2, IL-4, IL-7, IL-9, IL-15, and
IL-21). However, 
 
 
 
c
 
 
 
/
 
 
 
 mice have a B cell phenotype
corresponding closely to that of IL-7R
 
 
 
 
 
/
 
 
 
 mice (31,
32), suggesting that among known lymphokines, only
IL-7 is critically involved in B cell genesis and that the
other lymphokines using 
 
 
 
c may not be required for B
cell development.
Unlike lineage-restricted cytokine receptors belonging
to the hematopoietin receptor superfamily (33), the fms-
like tyrosine kinase-3 (flt3 or flk2) receptor is expressed pri-
marily at early stages of hematopoiesis and in particular
early lymphoid development (34). Although flt3 expression
is lost at the pre-B cell stage (35) and flt3 ligand (FL)–defi-
cient mice only have marginally reduced mature B cell
numbers and normal Ig levels (36, 37), there is ample evi-
dence that flt3 and its ligand indeed play an important role
in B cell development. Most importantly, the BM of flk2
and FL-deficient mice have reduced levels of B cell pro-
genitors (36, 38), including the common lymphoid pro-
genitor (CLP) (37). Furthermore, the combined action of
FL and IL-7 is both sufficient and strictly required for
stroma-independent in vitro B cell development from adult
multipotent hematopoietic progenitors (39).
Thus, we hypothesized that rather than a combination of
lymphokines, the concerted action of two cytokine recep-
tors—flt3, an early acting tyrosine kinase receptor and the
later acting hematopoietin receptor IL-7R
 
 
 
—might be in-
dispensable for B cell genesis in vivo. Herein we present
compelling evidence supporting this hypothesis. During
both fetal and adult hematopoiesis, mice deficient in the
expression of FL and IL-7R
 
 
 
 completely lack mature con-
ventional IgM
 
 
 
 B cells, IgA
 
 
 
 plasma cells, and B1 B cells,
and in striking contrast to FL or IL-7R
 
 
 
 single-deficient
mice, fail to produce circulating Ig.
 
Materials and Methods
 
Generation of Double Knockout Mice Deficient in FL and IL-7
 
 
 
Expression.
 
Mice deficient in FL (36) or IL-7R
 
 
 
 (26) expression
were generated as described previously. FL
 
 
 
/
 
 
 
 mice were on a
pure C57BL/6 background (36), whereas IL-7R
 
 
 
 
 
/
 
 
 
 mice had
been backcrossed for five generations with C57BL/6 mice. Mice
double deficient for FL and IL-7R
 
 
 
 expression were obtained by
crossbreeding of single FL
 
 
 
/
 
 
 
 and IL-7R
 
 
 
 
 
/
 
 
 
 mice and subse-
quent interbreeding of heterozygous FL
 
 
 
/
 
 
 
 IL-7R
 
 
 
 
 
/
 
 
 
 mice.
Mice used for experiments were obtained through breeding of
FL
 
 
 
/
 
  
 
  
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice, and C57BL/6 mice were used as WT
controls. All mice used for the study were genotyped using PCR
with specific primers to verify the absence of FL and IL-7R
 
 
 
genes (26, 36). All studies of adult B lymphopoiesis were per-
formed on age-matched mice, 8–12 wk old, kept under specific
pathogen-free conditions.
For analysis of embryonic development, timed pregnancies were
determined as described previously (40); the day the vaginal plug
was observed was considered as day 0. All performed experiments
were approved by the Ethical Committee at Lund University.
 
Tissues.
 
Peripheral blood (PB) was collected from the retro-
orbital sinus venous plexus or vena cava into heparinized tubes.
White blood cells were isolated using 1% dextran (Amersham
Biosciences) solution, and the remaining red cells were lysed using
ammonium chloride. BM cell suspensions were prepared by flush-
ing isolated tibiae and femora with PBS (Sigma-Aldrich) contain-
ing 5% FCS (BioWhittaker). Cell suspensions were prepared from
spleens, mesenteric LNs, and Peyer’s patches by gently breaking
up the tissues in PBS (Sigma-Aldrich) containing 5% FCS. Lamina
propria lymphocytes were isolated as described before (41).
Spleens and livers were collected from embryos at day 17–18 of
gestation, and cell suspensions were prepared by gently breaking
up the tissues in PBS (Sigma-Aldrich) containing 5% FCS.
 
mAbs and Flow Cytometry Analysis.
 
The following antibodies
were used for flow cytometry: anti-B220 (RA3–6B2), anti-
CD19 (1D3), anti-CD5 (53–7.3), anti-CD43 (S7), anti-NK1.1
(PK136), anti-IgM (R6–60.2), anti-CD3e (145–2C11), anti-
CD11b (M1/70) (all from Amersham Biosciences), and anti-
IgA (11–44–2) (Southern Biotechnology Associates, Inc.). Anti-
AA4.1 antibody was a gift from Dr. Ihor Lemischka (Princeton
University, Princeton, NJ). Isotype-matched controls used in-
cluded mouse IgG1, mouse IgG2a, rat IgG2a, rat IgG2b, and
hamster IgG labeled with appropriate fluorochromes (BD Bio-
sciences). Up to 10
 
6
 
 cells per sample were first incubated in PBS
(Sigma-Aldrich) containing 5% FCS (BioWhittaker) and Fc
block (CD16/CD32; BD Biosciences) to minimize nonspecific
binding. Cells were then labeled with the appropriate antibodies
for 15 min at 4
 
 
 
C in PBS containing 5% FCS. Finally, 7AAD was
added to exclude dead cells from the analysis. Samples were ana-
lyzed on FACSCalibur (Becton Dickinson). Between 50,000 and
400,000 events were collected, and analysis was performed using
CellQuest (Becton Dickinson) and FlowJo (Tree Star Inc.) soft-
ware. All FACS
 
®
 
 data were displayed using a log 10 scale.
 
Ig ELISA.
 
ELISA analysis was performed according to Eng-
vall and Perlman (42). Briefly, microtiter ELISA plates (Costar
Corning 3590) were plated with 100 
 
 
 
l/well of 10 
 
 
 
g/ml
catcher antibody in PBS and incubated overnight at 4
 
 
 
C. For
blocking of nonspecific binding, the solutions were replaced with
200 
 
 
 
l/well 1% BSA in PBS and incubated overnight at 4
 
 
 
C.
The plates were washed three times with 200 
 
 
 
l/well washing
buffer (0.05% Tween 20, 0.02% NaN3 in PBS) and then incu-
bated overnight at 4
 
 
 
C with different dilutions of the serumT
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samples (IgM, IgA: 1:50,00 and 1:20,000; IgG: 1:20,000 and
1:80,000). Serum from FL
 
 
 
/
 
  
 
  
 
IL-7R
 
 
 
 
 
/
 
 
 
 mice was in addition
diluted at 1:100 and 1:400 for all analysis. The plates were washed
three times with 200 
 
 
 
l/well washing buffer and further incu-
 
bated with 100 
 
 
 
l/well alkaline phosphatase (AP) coupled de-
tecting antibody (IgM: 1.2 
 
 
 
g/ml; IgG: 1.2 
 
 
 
g/ml), or biotin-
ylated anti-IgA (2.5 
 
 
 
g/ml), overnight at 4
 
 
 
C. Only for detection
of IgA, the plates were washed three times with 200 
 
 
 
l/well
washing buffer and incubated overnight at 4
 
 
 
C with 100 
 
 
 
l/well
AP conjugated with streptavidin (1 
 
 
 
g/ml). After washing three
times with 200 
 
 
 
l/well washing buffer, 100 
 
 
 
l/well AP develop-
ing solution was added (1 M diethanolamine, 4 mM MgCl
 
2
 
, pH
9.8 with freshly added 0.5 mg/ml pNPP [no. O-104; Sigma-
Aldrich]). The reaction was developed at room temperature and
measured at several time points on an ELISA reader at 415 nm.
The following antibodies were used: donkey anti–mouse IgM
(low cross reactivity to rat) (Jackson ImmunoResearch Laborato-
ries), donkey anti–mouse IgM AP (low cross reactivity to rat)
(Jackson ImmunoResearch Laboratories), donkey anti–mouse
IgG (low cross reactivity to rat) (Jackson ImmunoResearch Labo-
ratories), donkey anti–mouse IgG AP (low cross reactivity to rat)
(Jackson ImmunoResearch Laboratories), rat anti–mouse IgA
(C10–3; BD Biosciences), biotinylated rat anti–mouse IgA (C10–
1; BD Biosciences), and AP-conjugated streptavidin (Jackson Im-
munoResearch Laboratories).
 
D-J Rearrangement Analysis.
 
BM cells were suspended into
single cells by gentle mechanic stress and filtering to remove de-
bris. Genomic DNA was prepared using Trizol (GIBCO BRL)
according to the manufacturers instructions. D-J rearrangements
were then assayed by PCR using a protocol based on that by
Schlissel et al. (43). The D-J–rearranged and germline-configurated
DNAs were amplified in the same reaction by 30 cycles (94
 
 
 
C for
30 s, 60
 
 
 
C for 45 s, and 72
 
 
 
C for 1 min) using the DH and J3
primer at 1 
 
 
 
M and the Mu0 primer at 0.1 
 
 M final concentra-
tion. The Mu0 amplifies together with the J3 primer germline
DNA and the aim of using reduced amounts of Mu0 was to re-
duce the signal from the germline amplification. The PCR prod-
ucts were blotted onto Hybond N  nylon membranes (Amersham
Biosciences) using capillary blotting. Membranes were prehybrid-
ized in 5  Denhardt’s, 6   SSPE, 0.1% SDS, and 100  g/ml
Salmon Sperm DNA at 45 C for 60 min and hybridized with a
 -32P–labeled oligonucleotide complementary to the J3 region
(JH3) for 12 h at 45 C in the same solution. Membranes were
washed at room temperature in 2   SSC supplemented with 0.1%
SDS for 15 min and 0.1   SSC with 0.1% SDS for 5–10 min. The
hybridized membrane was then subject to autoradiography.
Figure 1. Mice double deficient in flt3 ligand and IL-7R  expression
show impairment in the development of lymphoid tissue. Photographs of
mesenteric and para-aortic LNs taken with 2.2 to 3.45 magnification; arrows
point to location of LNs. Bar, 2.2 cm.
Table I. Mice Double Deficient in flt3 Ligand and IL-7R  Expression Have Impaired Development of Lymphoid Tissues
Tissue
WT
Cellularity  106
FL / 
% WT control
IL-7R  / 
% WT control
FL /    IL-7R  / 
% WT control
BM 80 (11) 77 (16) 99 (7) 102 (8)
Spleen 187 (39) 60 (14) 22 (6) 16 (3)
PB 6.8 (1.7) (per ml) 73 (24) 25 (3) 10 (3)a
cMesenteric LNs 17 (3) 78 (19) 6.3 (1.2) Lackingb
dPeyer’s Patches number 7 (1) 4 (2) 2 (1) Lackingb
Peyer’s Patches total cellularity 1.7 (0.6) 53 (16) 5.5 (1.5)
All analysis of double knockout mice lacking FL and IL-7R  expression (FL /    IL-7R  / ) was done in parallel with age-matched 8–12-wk-old
WT control and single FL /  and IL-7R  /  mice. Data are expressed as means (SD) from 6-12 mice analyzed in each group.
a,bStatistically significant differences between single IL-7R  /  and FL /    IL-7R  /  mice, with P < 0.01 and P < 0.05, respectively.
cTotal cellularity in mesentheric LNs.
dNumber of Peyer’s Patches; mean (SD) values from WT, FL / , IL-7R  / , and FL /    IL-7R  /  mice.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Indispensable Role of IL-7R  and flt3 in B Cell Genesis 1498
Figure 2. Adult mice double deficient in Flt3 ligand and IL-7R  expression lack B cells in the PB, spleen, and BM. PB, spleen, and BM cells from
8–12-wk-old mice were stained with mAbs against B220, IgM, CD19, and NK1.1 (as described in Materials and Methods). (A) Plots of B220 and IgM
expression in WT, FL-deficient, IL-7R –deficient and FL /    IL-7R  /  double deficient mice, respectively. Numbers represent mean values from
6–12 mice. (B) Total number of B220  cells coexpressing IgM, B220  cells expressing CD19 (C), B220  cells (D), and B220  cells expressing NK1.1T
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The following oligonucleotides were used for PCR: DH, 5 -
GGAATTCG(A/C)TTTTTGT(C/G)AAGGGATCTACTAC-
TGTG-3 ; J3, 5 -GTCTAGATTCTCACAAGAGTCCGATA-
GACCCTGG-3 ; Mu0, 5 -CCGCATGCCAAGGCTAGCCT-
GAAAGATTACC-3 . The following oligonucleotides was used for
hybridization: JH3, 5 -AGACAGTGACCAGAGTCCCTTGG-3 .
Expression of B Cell Genes. Total RNA was prepared using
RNAzol (Tel-Test) from 10 million BM cells and dissolved in 50
 l. 10  l was used for cDNA preparation in a total volume of 20
 l using Superscript II and random primers (Life Technologies).
1  l cDNA was used per PCR reaction, except serial fivefold di-
lutions for HGPRT starting with 1  l. The following conditions
were used for PCR reactions: HGPRT, 30 cycles at 55 C an-
nealing temperature; all other reactions, 35 cycles at 55–58 C an-
nealing temperature.
The following primer sequences were used: pax-5, sense, 5 -
TCCTCGGACCATCAGGACAG-3  and antisense, 5 -CCT-
GTTGATGGAGCTGACGC-3 ; for mb-1 sense, 5 -GGGGT-
CTAGAAGCCCTCAGAGCCCTGCCTC-3   and  antisense,
5 -TGCCGAATTCCTGGTAGGTGCCCTGGAGTC-3 ; and
CD19, sense, 5 -TACCTTAGTAGGAGGCAGGCC-3  and an-
tisense, 5 -CCGGAACATCTCCCCACTAT-3 .
Statistics. All results were expressed as means (  SD). The
statistical significances between groups were determined using the
Student’s t test.
Results
Mice Double Deficient in flt3 Ligand and IL-7R  Expression
Are Severely Immune Compromised and Lack Peyer’s Patches
and Identifiable LNs. Initially, FL /    IL-7R  /  mice
showed reduced survival compared with either FL /  or
IL-7R  /  mice. The reduced survival was most likely
due to enhanced susceptibility to opportunistic infections,
since breeding and housing of FL /    IL-7R  /  mice in
specific pathogen-free conditions resulted in mice with a
normal life span.
No significant differences in BM cellularity were ob-
served between WT, IL-7R  / , FL / , or FL /    IL-
7R  /  mice (Table I). In contrast, spleen cellularity in
FL / , IL-7R  / , and FL /    IL-7R  /  mice was re-
duced to 60, 22, and 16%, respectively, of WT controls.
The total peripheral white blood cell counts in FL /    IL-
7R  /  mice were more significantly reduced (to 10% of
WT mice) compared with either single FL /  or IL-7R  / 
mice (Table I). Previous studies have reported reduced
cellularity in the LNs and Peyer’s Patches of IL-7R  / 
mice (26, 44). In contrast to IL-7R  /  mice in which LNs
were present but with reduced cellularity, no peripheral
(e.g., para-aortic [Fig. 1], axial, and inguinal [not depicted])
or mesenteric LNs were identifiable in FL /    IL-7R  / 
mice (Table I and Fig. 1). Similarly, unlike IL-7R  / 
mice where Peyer’s Patches were present at reduced
numbers (and cellularity), these could not be detected in
FL /    IL-7R  /  mice (Table I). Collectively, the se-
vere lymphoid hypoplasia detected in FL /    IL-7R  / 
mice suggests a critical and complimentary role of flt3 and
IL-7R  signaling in lymphoid development.
Absence of Mature IgM  B Cells in the Blood, Hematopoietic,
and Lymphoid Tissues of Adult FL /    IL-7R  /  Mice.
The absence of identifiable LNs in FL /    IL-7R  / 
mice suggested that the generation of mature B cells may
be more severely affected in FL /    IL-7R  /  than ei-
ther FL /  or IL-7R  /  mice. Thus, the presence of ma-
ture B220 IgM  B cells in the PB, spleen, and BM of
8–12-wk-old FL /    IL-7R  /  mice was next investi-
gated (Fig. 2, A and B). As reported previously (36),
B220 IgM  cells were reduced by 53–75% in FL /  mice
(Fig. 2, A and B), whereas IL-7R  /  mice had clearly re-
duced but detectable B220 IgM  cells in PB, BM, and
spleen in agreement with previous studies (26) (Fig. 2, A
and B). In striking contrast, FL /     IL-7R  /  mice
completely lacked mature B220 IgM  B cells in the PB,
spleen, and BM (Fig. 2, A and B).
The absence of B cells in FL /    IL-7R  /  mice was
further confirmed by a complete lack of B220 CD19  cells
in PB, spleens, and BM, whereas these were present in IL-
7R  /  mice (Fig. 2 C). Although present at dramatically
reduced levels compared with FL /  and IL-7R  /  mice,
B220  cells were detectable in the PB, spleen, and BM of
FL /    IL-7R  /  mice (Fig. 2 D). Noteworthy, how-
ever, most of the rare B220  cells detected in FL /    IL-
7R  /  mice coexpressed NK1.1 (Fig. 2 E), consistent
with the phenotype of NK cell progenitors rather than
bona fide B cells (45). Thus, in contrast to either FL /  or
IL-7R  /  mice, adult FL /    IL-7R  /  mice com-
pletely lack B cells.
In contrast to the complete absence of mature B cells,
the number of PB T (CD3 ) cells was only slightly reduced
in FL /    IL-7R  /  mice compared with IL-7R  / 
mice (Table II), whereas the number of myeloid (CD11b )
cells was comparable to that of FL /  mice (Table II).
Absence of IgA  Plasma Cells in Lamina Propria and Perito-
neal B1 Cells in Mice Double Deficient in flt3 Ligand and IL-
7R  Expression. Since production of IgA has been dem-
onstrated to be regulated by mechanisms distinct from
those of IgM (46), FL /    IL-7R  /  mice were next
examined for the presence of IgA  plasma cells in the lam-
ina propria of the gut (Fig. 3 A).
The number of lymphocytes in the lamina propria was
reduced by 79   4% in FL /      IL-7R  /  mice,
whereas only a slight reduction in lymphocyte numbers
was detected in the lamina propria of FL /  and IL-7R  / 
mice (14   12% and 34   4% reduction, respectively).
Strikingly, whereas IgA  plasma cells were present in nor-
mal numbers in FL /  mice and reduced by 75% in IL-
7R  /  mice, IgA  plasma cells were completely absent in
FL /    IL-7R  /  mice (Fig. 3 A).
(E). BM cellularity represents cell counts from both tibiae and femora, whereas total number of white blood cells in PB was calculated per 1 ml. Data in
B–E are expressed as mean values (SD) from 6–12 age-matched mice in each group. *Statistically significant differences (P   0.01) between IL-7R  / 
and FL /    IL-7R  /  mice. 0, no B220 IgM  or B220 CD19  cells were detected in FL /    IL-7R  /  mice.T
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B1a cells, characterized by expression of low levels of
B220 and intermediate levels of CD5, represent a subset of
self-replenishing B cells that arise early during fetal devel-
opment before the appearance of conventional B cells (47,
48). Several studies suggest that B1 cells are regulated by
mechanisms distinct from those of conventional B cells.
This is supported by studies of  c /  and IL-7 /  mice in
which conventional B cells are dramatically reduced,
whereas B1 cells are present at near normal levels (28, 31).
Whereas the number of peritoneal leukocytes was normal
(106   4%) in FL /  mice and present at almost normal
levels (70   10%) in IL-7R  /  mice, they were signifi-
cantly reduced in FL /    IL-7R  /  mice (27   4%;
P   0.01 compared with IL-7R  / ). Whereas the total
number of B1a cells was normal in FL /  mice and re-
duced by 63% compared to control levels in IL-7R  / 
mice, they were completely absent in FL /    IL-7R  / 
mice (Fig. 3 B). Thus, signaling through flt3 and IL-7R  is
also critical for generation and/or maintenance of B1a cells.
Mice Double Deficient in flt3 ligand and IL-7R  Expression
Fail To Produce Igs. Although  c /  mice and IL-7R  / 
mice have reduced numbers of conventional B cells, these
mice have normal levels of circulating Ig (30, 31). This
could reflect that residual numbers of conventional B cells
and/or normal numbers of B1 cells (known to produce all
Ig types) (47) are capable of sustaining Ig production in
Table II. Presence of T and Myeloid Cells in Mice Double Deficient in flt3 Ligand and IL-7R  Expression
Mouse
Total number of T (CD3+) cells 
per 1 ml   104
Total number of myeloid (CD11b+) cells 
per 1 ml   104
WT 163 (47) 100 (30)
FL /  220 (13) 73 (21)
IL-7R  /  21 (8) 120 (29)
FL /    IL-7R  /  12 (6) 70 (16)
Cells from peripheral blood from 8–12-wk-old mice were stained with mAbs against CD3 and CD11b (described in Materials and Methods). Data
represent total number of cells and are expressed as mean values (SD) from four age-matched mice in each group.
Figure 3. Mice double deficient in Flt3 ligand and IL-7R  expression
have reduced numbers of IgA  plasma cells and B1 cells. (A). Cells from
lamina propria of 8–12-wk-old WT, FL / , IL-7R  / , and FL /   
IL-7R  /  mice were stained with mAbs against IgA (as described in
Materials and Methods). 0, no IgA  cells were detected in FL /    IL-
7R  /  mice. (B) Cells from peritoneal lavage of 8–12-wk-old WT,
FL / , IL-7R  / , and FL /    IL-7R  /  mice were stained with
mAbs against B220 and CD5 (described in Materials and Methods). All
data are expressed as mean values (SD) from three to six mice. *Indicates
statistically significant differences (P   0.01) between IL-7R  /  and
FL /    IL-7R  /  mice. 0, no B220 CD5  cells were detected in
FL /    IL-7R  /  mice.
Table III. Mice Double Deficient in flt3 Ligand and IL-7R  
Expression Do Not Produce Igs
Mouse IgM levels IgG levels IgA levels
 g/ml  g/ml  g/ml
WT 198   95 625   117 186   84
FL /  Normala Normala Normala
IL-7R  /  237   53 501   314 39   21
FL /    IL-7R  /  0b (bd) 0b (bd) 0b (bd)
The serum levels of IgM, IgG, and IgA were analyzed using ELISA
(described in Materials and Methods) with the following detection
limits: 0.5  g/ml for IgM, 0.15  g/ml for IgG, and 0.08  g/ml for IgA.
6–10 age-matched mice were analyzed per each group, homozygous
Rag /  mice were used as negative controls (66). bd, below detection.
aReference 36.
bStatistically significant difference (P < 0.01) between IL-7R  /  and
FL /    IL-7R  /  mice.T
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these mice. Thus, we next examined the levels of produc-
tion of IgM, IgG, and IgA in the serum of either FL / ,
IL-7R  / , or FL /    IL-7R  /  mice by a sensitive
ELISA assay. In contrast to FL /  or IL-7R  /  mice,
which produce normal levels of serum IgM and IgG, ab-
solutely no IgM or IgG was detectable in the serum of
FL /    IL-7R  /  mice (Table III). Similarly, IgA, which
was present at slightly reduced levels in IL-7R  /  mice,
was undetectable in FL /    IL-7R  /  mice (Table III).
Similar findings were observed for IgD (unpublished data),
further confirming the complete absence of mature func-
tional B cells in adult FL /    IL-7R  /  mice.
Absence of Detectable Committed B Cell Progenitors in
FL /    IL-7R  /  Adult BM and Fetal Liver. Since no
mature B cells were detected in adult FL /    IL-7R  / 
mice, we next investigated whether committed B cell pro-
genitors could be detected in FL /    IL-7R  /  BM.
Recent studies have demonstrated that little or no B cell
development takes place in the BM of IL-7 /  and IL-
7R  /  mice after 7 wk of age, reflected in virtually no
detectable B cell progenitors (28, 29). In agreement with
this, using a similar staging (29, 49, 50) we found that
B220 CD43 AA4.1 CD19  pre-pro-B cells were re-
duced by  99% in FL /     IL-7R  /  BM, whereas
B220 CD43 AA4.1 CD19  pro-B and pre-B cells were
nondetectable (Fig. 4 B). Interestingly, FL /  mice also
showed a dramatic (97.5%) reduction in B220 CD43 
AA4.1 CD19  pre-pro-B cells and, as previously shown
(37), also reduced levels of pro-B (76%) and pre-B (62%)
cells (Fig. 4 B).
Compared with FL /  and IL-7R  /  mice, only very
low levels of D-J rearrangement could be detected in the
BM of FL /    IL-7R  /  mice (Fig. 5 A). The develop-
ment of mature B cells is dependent on the expression of
several transcription factors (25, 51). The B cell lineage–
specific activator protein encoded by the Pax5 gene (52)
appears to be crucial for B cell development, which in
Pax5-deficient mice is blocked at the pro-B cell stage (53,
54). Pax5 RNA was highly expressed in the BM of FL / 
mice, reduced in IL-7R  /  mice, and was completely
undetectable in FL /    IL-7R  /  BM, in agreement
with the complete absence of pro-B cells and all subsequent
stages of B cell development (Fig. 5 B). Similarly, mb-1 and
CD19, two direct target genes of Pax5 (55–58), were ex-
pressed in FL /  BM cells, reduced in IL-7R  /  BM
cells, but completely absent in FL /    IL-7R  /  mice
Figure 4. Mice double deficient
in flt3 ligand and IL-7R  expres-
sion show dramatic reductions in
early and late B cell progenitors
in adult BM. (A) Schematic illus-
tration of cell surface phenotype,
B cell gene expression, and D-J
rearrangement during normal B
cell development. Also shown
are expression patterns for flt3
and IL-7R. MPP, multipotent
progenitor, Lin Sca-1 c-kit flt3 
IL-7R  (63). CLP, common
lymphoid progenitor; sIgM, sur-
face IgM. (B) BM cells from
WT, FL / , and FL /     IL-
7R  /  mice were investigated
for the presence of B cell pro-
genitors as described previously
(29, 50); pre-pro-B cells
(B220 CD43 AA4.1 CD19 ),
pro-B cells (B220 CD43 -
AA4.1 CD19 ), pre-B cells
(B220 CD43 CD19 ), and im-
mature/mature B cells (B220 -
IgM ). Results are mean values
(SD) from six to twelve mice for
each group and are expressed as
percentages of WT controls (no
significant differences in BM cel-
lularity between different geno-
types). *Indicates statistically sig-
nificant differences (P    0.01)
between FL /  and FL /    IL-
7R  /  mice. 0, no pro-B, pre-
B, or B220 IgM  cells were de-
tected in FL /      IL-7R  / 
mice.T
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(Fig. 5 B). Thus, flt3 and IL-7R  signaling appears to be
essential for commitment to a Pax5-dependent B cell stage.
Due to the complete absence of not only conventional B
cells but also B1 cells in adult FL /    IL-7R  /  mice,
we next compared fetal B lymphopoiesis in IL-7R  / 
and FL /    IL-7R  /  mice. B220  IgM  B cells were
present, although at reduced levels, in the fetal spleen and
liver of IL-7R  /  mice, in striking contrast to FL /   
IL-7R  /  mice in which no B220 IgM  B cells were
detectable (Fig. 6 A). Furthermore, in contrast to IL-
7R  / –deficient mice, FL /    IL-7R  /  fetal livers
lacked detectable B220 CD19  and B220 AA4.1  cells,
suggesting that generation of committed B cell progenitors
is strictly dependent on IL-7R  and flt3 signaling also dur-
ing fetal development (Fig. 6 B).
Discussion
Several cytokines have been shown to promote B cell
development in vitro and in vivo (25, 59), but extensive
studies of mice deficient in different cytokine ligands and
receptors have so far failed to support an indispensable role
for cytokines in B cell development. Although the produc-
tion of mature B cells in the BM of IL-7 and IL-7R –defi-
cient mice takes place almost exclusively during fetal and
postnatal development (9, 26, 27, 30), a stable pool of ma-
ture B cells are maintained throughout adult life in periph-
eral organs, sustaining normal levels of circulating Ig (9, 26,
27, 30). These B cells might largely be offspring of fetally
derived B1 cells, and since present at normal levels in IL-7–
deficient mice they have been suggested to represent an
important IL-7–independent pathway for B cell develop-
ment (28). Alternatively, fetal B cell development and
maintenance of B cells and Ig production during adult life
might be dependent on the concerted action of IL-7 with
one or multiple other cytokines. However, mice deficient
in the  c chain receptor, required for signaling of six differ-
ent lymphokines (including IL-7), express a similar pheno-
type to that of IL-7R  /  mice (31, 32), suggesting that
among known lymphokines only IL-7 plays a nonredun-
dant function in B cell development. As the result of these
observations, an alternative hypothesis emerged, namely
that signaling through cytokine receptors might not be
strictly required for the development of mature B cells.
Through similar findings, the fundamental importance of
cytokine signaling has also been questioned in the develop-
ment of a number of other blood cell lineages (6–8, 10–12,
14–17, 20–24).
In the present study, we unequivocally demonstrate that
signaling through two separate families of cytokine recep-
tors (i.e., an “early acting” receptor tyrosine kinase and a
“later acting” hematopoietin receptor) are indispensable for
fetal and adult B cell development. This conclusion is based
on multiple lines of evidence obtained using methods capa-
ble of detecting minute levels of B cells. In contrast to ei-
ther FL /  or IL-7R  /  mice, peripheral and mesenteric
LNs and Peyer’s Patches were not identifiable in FL /   
IL-7R  /  mice. Furthermore, IgM  B cells were found
to be completely lacking in the blood, spleen, and BM of
adult FL /    IL-7R  /  mice, whereas, consistent with
previous studies, B cells were present (at reduced levels) at
all sites in IL-7R  /  mice. Similarly, whereas IgA 
plasma cells were found at normal or near normal levels in
either FL /  or IL-7R  /  mice, they were undetectable
in FL /    IL-7R  /  mice.
Flt3 and IL-7R  signaling proved essential not only for
development of conventional B cells but also for B1 cells
and fetal B lymphopoiesis. B1 cells, arising early during fetal
development before the appearance of conventional B cells,
are believed to be regulated via distinct pathways to those of
conventional B cells (28, 47, 48). In fact, before the present
study a crucial role for cytokines in B1 cell genesis had not
Figure 5. Absence of expression
of Pax5 and Pax5 target genes in
BM of adult FL /    IL-7R  / 
mice. (A) DNA was isolated from
BM of WT, FL / , IL-7R  / ,
and FL /     IL-7R  /  mice
and D-J rearrangement assessed
by PCR (described in Materials
and Methods). Representative
results from two out of seven
analyzed mice. (B) RNA was
isolated from BM of WT, FL / ,
IL-7R  / , and FL /      IL-
7R  /  mice (described in Mate-
rial and Methods) and expression
of Pax5, mb-1, and CD19 (top)
or HGPRT (bottom) analyzed
by RT-PCR. Data are from one
of three experiments with similar
results.T
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been identified. In this regard, both  c /  and IL-7–defi-
cient mice have been shown to have normal levels of B1
cells but reduced conventional B cells (31, 28), and herein
we show that single FL /  mice have near normal levels of
peritoneal B1 cells, whereas IL-7R  /  mice have a 63%
reduction. In contrast, B1 cells are completely absent in
FL /    IL-7R  /  mice, demonstrating that IL-7R  and
flt3 signaling are indispensable for B1 cell development and/
or maintenance. It is noteworthy that in IL-7R  /  mice
we found a significant reduction in B1 cells, whereas B1
cells are normal in IL-7 /  mice (28). Since another cyto-
kine, thymic stromal lymphopoietin, has been shown to uti-
lize the IL-7R  in its signaling (60), this might suggest that
thymic stromal lymphopoietin together with FL and IL-7
might be critically involved in generation of B1 cells.
A critical role for flt3 and IL-7R signaling in fetal B cell
development was further substantiated by a complete ab-
sence of mature B220 IgM  B cells, in striking contrast to
IL-7R  /  mice. Furthermore, whereas the fetal liver
of IL-7R  /  mice contained B220 CD19  and B220 
Figure 6. Lack of detectable mature B
cells and B cell progenitors during fetal devel-
opment of mice double deficient in flt3
ligand and IL-7R  expression. Spleen and
liver cells isolated from embryos at day 17–18
of gestation were stained with mAbs against
B220, CD19, IgM, and AA4.1 (Materials
and Methods). (A) Plots of B220, CD19,
and IgM expression in the spleens of WT,
IL-7R  / , and FL /    IL-7R  /  mice.
Numbers represent mean values from three
to eight mice. (B) Plots of B220, CD19, and
IgM expression in the livers of WT, IL-
7R  / , and FL /      IL-7R  /  mice.
Numbers in A and B represent mean values
(percentage of total cells in lymphoid gate)
from three to eight mice.T
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AA4.1  B cell progenitors, no B220  cells coexpressing
CD19 or AA4.1 were detected in the fetal liver of FL /   
IL-7R  /  mice, suggesting a critical role of FL and IL-7
in the earliest stages of fetal B cell commitment and devel-
opment. Finally, and most strikingly, whereas a highly sen-
sitive ELISA assay confirmed that the residual levels of
B cells in adult IL-7R  /  mice can produce normal Ig
levels, no Ig production (IgM, IgG, IgA and IgD) was ob-
served in FL /    IL-7R  /  mice.
Although certain transcription factors have been demon-
strated to be critically involved in B cell commitment and
development (25, 51), and our present studies demonstrate
that B cell genesis is also strictly dependent on specific cy-
tokine signaling, the potential cross talk between the two
remain poorly understood. It is well known, however, that
transcription factors can regulate cytokine receptor expres-
sion (4), but there is less evidence for a role of cytokine sig-
naling in the regulation of transcription factor expression. It
is striking that expression of Pax5, the proposed master reg-
ulator of B cell commitment and development (53, 54), was
completely absent in the BM of FL /    IL-7R  /  mice,
as were the direct Pax5 target genes mb-1 and CD19 (55–
58). This could potentially reflect an indispensable role of
flt3 and IL-7R  in regulation of Pax5 expression, but since
pro-B cells and all downstream stages of B cell development
were completely lacking in the BM of FL /    IL-7R  / 
mice, we rather favor that flt3 and IL-7R  are absolutely
required to promote B cell development to a Pax5-depen-
dent stage. This is interesting in the context that Pax5 is
thought to act as a “B cell lineage locker,” restricting the
lineage potentials of otherwise multipotent progenitors to a
committed B cell fate (54, 61), implicating that B cell com-
mitment might be dependent on signaling through flt3 and
IL-7R . Although FL /    IL-7R  /  BM showed low
levels D-J rearrangement, this could potentially derive from
cells not committed to the B cell lineage, since D-J rear-
rangement can be found in T cell progenitors (62).
Despite flt3 and c-kit being coexpressed at early stages of
B cell development, including CLP (37, 63), the present
findings demonstrate a distinct role of flt3 but not c-kit in
early B cell development, since  c /    c-kit /  mice pro-
duce B cells at levels comparable to that of single  c / 
mice (64). Although the mechanisms by which flt3 and IL-
7R  interact to maintain B cell production remains to be
established, the function of the two cytokine receptors are
evident at distinct and overlapping stages of B cell develop-
ment (34, 65). Flt3 is expressed (34, 63) at earlier stages than
IL-7R , and FL-deficient mice have a defect primarily in
early B cell progenitors, including the CLP (37). In contrast,
IL-7R  is primarily expressed at later stages of B cell devel-
opment, and IL-7–deficient mice have normal levels of
CLPs (29) but reduced levels of B cell progenitors and ma-
ture B cells (26, 27). However, the complete absence of
conventional and B1 cells in fetal and adult FL /    IL-
7R  /  mice most likely also reflects important synergistic
interactions and potential cross-talk between these two cy-
tokine receptor signaling pathways during multiple stages of
B cell development (from CLP to pre-B cells) where both
receptors are coexpressed. This is supported by the potent in
vitro synergy between FL and IL-7 in promoting B cell de-
velopment and expansion from adult uncommitted BM
progenitors in which the combined action of FL and IL-7
proved both sufficient and absolutely essential (39).
The potent synergy between one of the cytokine tyrosine
kinase receptors flt3 and/or c-kit and multiple members
of the hematopoietic receptor superfamily in promoting
growth and development of different blood cell lineages is a
well-described in vitro phenomenon (2, 3, 34). The present
findings propose an important physiological synergy be-
tween an early acting tyrosine kinase receptor and late act-
ing hematopoietin receptor during B cell development,
rather than between intensively explored combinations of
hematopoietic lineage factors. This apparent synergy may
not only be critical for B cell development but may also
prove essential for the development of other blood cell lin-
eages. In support of this hypothesis, a combined deficiency
in both c-kit and  c chain receptor expression has been
shown to result in a profound block in early thymocyte de-
velopment (64). Although c-kit /  mice die 2–6 d after
birth (due to anemia) complicating further analysis and it re-
mains unclear which (one or multiple) of the 6 cytokines
acting through the  c chain receptor are involved in thy-
mocyte development, this finding lends further support to-
ward an essential role of interactions between early acting
cytokine tyrosine kinase receptors and later acting hemato-
poietin receptors in blood lineage development.
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